Headquartered in Houston, Texas, U.S. Physical Therapy is a national operator of outpatient physical therapy clinics and a provider of industrial injury prevention services. It operated 799 locations at September 30, 2026. U.S. Physical Therapy has a marketCapitalizationof USD 1.48 billion and a price …
Vendome Acquisition Corporation I is a blank check company incorporated in the Cayman Islands and headquartered in Park City, Utah. It was formed to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. Its …
Headquartered at 1800 Owens Street in San Francisco, California, Vir is a Delaware corporation and a clinical stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its common stock trades …
Headquartered at 4009 N. Rodney Parham Road in Little Rock, Arkansas, Westrock Coffee is a Delaware corporation and an integrated beverage solutions platform serving the world's largest brands across packaged coffee, tea, extracts and flavors and ingredients. Westrock Coffee has a marketCapitalizationof USD 877.67 …
WhiteHorse Finance is headquartered at 1450 Brickell Avenue in Miami, Florida, and its common stock trades on theNasdaqGlobal Select Market. It is an externally managed, non-diversified, closed-end management investment company that has elected to be treated as a business development company under the Investment …
Xencor is a Delaware corporation headquartered at 465 North Halstead Street in Pasadena, California, with office and laboratory space in Monrovia, California. It is a clinical stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune …
Headquartered at 1375 West Fulton Street in Chicago, Illinois, Xeris Biopharma is a Delaware corporation whose commercial products are Recorlev, Gvoke and KEVEYIS. Xeris has a marketCapitalizationof USD 2.77 billion and no reported price toEarningsratio. Its fiscal year ends December 31.
Mentari Therapeutics, Inc., formerly known as InMed Pharmaceuticals Inc., filed a Form 8-K current report on November 9, 2026, announcing the completion of its previously disclosed merger with Mentari Therapeutics, Inc., a Delaware corporation.
LKQ Corporation filed a current report on November 9, 2026, disclosing that Salvatore A. Abbate's start date as President and Chief Executive Officer and Board member was accelerated from December 15, 2026 to November 9, 2026.
Quanterix Corporation filed a Form 8-K with the SEC on November 9, 2026, announcing its financial results for the third fiscal quarter ended September 30, 2026, alongside presentation slides furnished for its earnings call held the same day.